This announcement is a separate document:
江苏亚虹医药科技股份有限公司自愿披露关于在第27届全国临床肿瘤学大会暨2024年CSCO学术年会上发布APL-1702国际多中心Ⅲ期临床试验相关数据的公告
Jiangsu Yahong Pharmaceutical Technology Co., Ltd. voluntarily disclosed the announcement on the release of data related to the APL-1702 international multi-center phase III clinical trial at the 27th National Clinical Oncology Conference and the 2024 CSCO Academic Annual Conference
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated